BXP Completes Partial Sale of AstraZeneca Research Center
Boston Properties completed its partial sale of a Kendall Square life science project that values the two-building development at over $2,000 per square foot.
Children’s Hospital to Anchor New Fenway Development
Boston Children’s Hospital will acquire nearly half of a new Fenway life science complex being developed by Alexandria Real Estate Equities and Samuels & Associates.
Greatland Buys Newton Office Park after Alexandria’s Exit
Boston-based Greatland Realty Partners and Barings acquired a Newton office park where life science developer Alexandria Real Estate Equities had planned a lab conversion.
Alexandria Unloads Five-Building Lab Portfolio for $365M
Life science developer Alloy Properties added to its Boston-area portfolio with acquisition of five buildings totaling 425,000 square feet in Cambridge and Waltham.
Alexandria Buys Astrazeneca Campus for $273M
Astrazeneca Pharmaceuticals sold its 43-acre campus in Waltham for $273 million as it prepares to depart for a Kendall Square development.
Jumbo Capital Sells Bedford Life Science Property for $132M
Quincy-based Jumbo Capital sold a Bedford life science property for nearly double its 2020 acquisition price, after securing a lease extension from an anchor tenant in late 2021.
BXP Expands Suburban Lab Portfolio with $100M Buy
Boston Properties added to its suburban life science portfolio with the $100 million acquisition of a pair of Waltham lab properties totaling 153,000 square feet.
Developers Buy Boston Landing Lab Site for $67M
Developer Lendlease in partnership with investor Ivanhoé Cambridge has acquired a development parcel at Boston Landing for $67 million with plans to break ground on a 320,000-square-foot life science building in June 2022.
Behind BioMed’s Buying Spree
Investors in life science developer BioMed Realty’s parent, a Blackstone Real Estate fund, were in no hurry to cash out and take their profits in 2020 as the pandemic was making the biopharma sector more attractive than ever. So the private equity giant gave them a new, multi-billion-dollar option.
Building a Foundation for Income and Growth
Ryan McDonough has $360 million in fresh equity commitments from institutions and high net worth sources to invest in East Coast commercial real estate as head of acquisitions for Boston-based Marcus Partners.
Lab Developer Buys Watertown, South Boston Properties for $81.2M
San Diego-based life science developer Phase 3 Real Estate Partners has acquired a pair of properties in Watertown and South Boston for $81.2 million.
Lab Developer Buys Waltham Properties for $340M
The $340-million acquisition of a pair of Waltham office campuses will give the new owners the opportunity to add lab-ready space for life science companies.
Big Lab Conversion Set to Begin in Seaport
BioMed Realty is joining the procession of life science developers to Boston’s Seaport District with the acquisition of the former John Hancock corporate headquarters at 601 Congress St.
Burlington Life Science Campus Sold for $200M
EMD Millipore Corp. has acquired its 4-year-old Burlington research campus from the original developer for $200 million.
Blackstone Buys Cambridge-Focused Portfolio for $3.45B
Blackstone Property’s life science arm will become the largest landlord in the industry’s Cambridge hub with the pending $3.45 billion acquisition of a 2.3-million-square-foot office-lab portfolio from Brookfield Asset Management.
Capital Markets Look for Clarity
There remains plenty of capital for real estate ventures and funds are being raised, but investors are selective on where that capital is being placed.
A New Niche for Life Science Expansion
Late-night Zoom calls to Hong Kong are just part of the daily drill for Matthew Powers, a Boston real estate executive named in November to head Nan Fung Life Science Real Estate and a man in charge of spending $1 billion on acquisitions nationally this year.
Hong Kong Investor Makes $115M Boston Acquisition
Hong Kong real estate investor Nan Fung has made its first acquisition in Boston just months after establishing a new U.S. office to pursue life science properties, resulting in a quick windfall for the previous owner of 13 months.
Alexandria Makes Another Big Bet on Suburbs with Newton Purchase
Life science developer Alexandria Real Estate Equities has bought its second suburban Boston office property in the past month, acquiring a Newton complex near the MBTA’s Riverside station for $235 million.
